Citation Impact
Citing Papers
Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitis and renal involvement: A prospective, randomized study
1998
EULAR recommendations for the management of primary small and medium vessel vasculitis
2008 Standout
A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies
2003 Standout
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel
2000 Standout
10 Disease assessment and management of the vasculitides
1997
Immunogenicity of two accelerated hepatitis B vaccination protocols in liver transplant candidates
2001
Small-Vessel Vasculitis
1997 Standout
IMMUNOLOGIC DEFECTS AND VACCINATION IN PATIENTS WITH CHRONIC RENAL FAILURE
2001
A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized wegener's granulomatosis
1997
T lymphocytes in patients with primary vasculitis: expansion of CD8+ T cells with the propensity to activate polymorphonuclear neutrophils
2008
Evidence‐based treatment of systemic vasculitis
2000
Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosis
2009
Efficacy of repeated high‐dose hepatitis B vaccine (80 μg) in patients with chronic liver disease
2005
Treatment of Antineutrophil Cytoplasm Autoantibody-Associated Systemic Vasculitis: Initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group
1997
Improved Immunogenicity of a Novel Third-Generation Recombinant Hepatitis B Vaccine in Patients with End-Stage Renal Disease
2004
An interdisciplinary approach to the care of patients with Wegener's granulomatosis: Long-term outcome in 155 patients
2000 Standout
Effectiveness of TNF-alpha blockade with infliximab in refractory Wegener's granulomatosis
2002
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
2009 Standout
Management of Chronic Kidney Disease Patients in the Intensive Care Unit: Mixing Acute and Chronic Illness
2017 Standout
Therapy for the maintenance of remission in sixty‐five patients with generalized Wegener's granulomatosis. Methotrexate versus trimethoprim/sulfamethoxazole
1996
Primary systemic vasculitis
1997
Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force
2007
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
2010 Standout
Pathogenesis of ANCA-associated systemic vasculitis
2000
Pulmonary Wegener's Granulomatosis
1998
BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis
2007
Sinonasal Computed Tomography in Patients With Wegener's Granulomatosis
2005
Mycophenolate Mofetil for Maintenance Therapy of Wegener's Granulomatosis and Microscopic Polyangiitis
1999
Long-term patient survival in ANCA-associated vasculitis
2010 Standout
Efficacy of transbronchial biopsy in pulmonary vaculitides
1997
Epidemiology of Wegener's granulomatosis in Northern Norway
2000
Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies
2006 Standout
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
The value of pulse cyclophosphamide in ANCA‐associated vasculitis: meta‐analysis and critical review
2001
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
The Enigmatic Epidemiology of Nasopharyngeal Carcinoma
2006 Standout
An approach to the diagnosis and management of systemic vasculitis
2010
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
HLA and nasopharyngeal carcinoma in Malays
1985
TNF‐mediated inflammatory disease
2007 Standout
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Works of A. Beigel being referenced
MRI of the nasal cavity, the paranasal sinuses and orbits in Wegener's granulomatosis
1997
Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with wegener's granulomatosis
1994
Magnetresonanztomographische Kennzeichen der Wegenerschen Granulomatose im Kopfbereich
1992
Clinical experience with a new recombinant hepatitis-B vaccine in previous non-responders with chronic renal insufficiency.
1996
Verteilungsmuster von Histokompatibilit�tsantigenen (HLA) bei Nasopharynxtumoren
1983
Histokompatibilit�tsmuster (HLA-Antigene) bei Wegenerscher Granulomatose
1981